Impaired pneumococcal immunity in children after treatment for acute lymphoblastic leukaemia

Although the substantial risk for invasive pneumococcal disease is well recognized in children after allogeneic stem cell transplantation, little is known about the specific immunity against pneumococci in children after cytotoxic therapy for acute lymphoblastic leukaemia (ALL).




Protected Content

This content is for MAMLS members only.

Want to see what you’re missing out on?
Become a MAMLS member today!

Already a MAMLS member?
Log In!